Skip to content

PTSD: all studies

Page 154 of 211: studies 1,531 to 1,540 of 2,101, newest first. Back to the PTSD overview

Research

Gli psichedelici: quanto è efficace e sicuro il loro possibile impiego in psichiatriae psicoterapia? Lo stato delle evidenze

PNEI REVIEW April 1, 2023 Francesco Dente

Nell'ultimo decennio la ricerca sull'utilizzo terapeutico degli psichedelici ha subito un'impennata, soprattutto per quanto riguarda la loro poten- ziale applicazione nel trattamento dei disturbi psichiatrici. In questi studi è stata indagata la sicurezza e l'efficacia delle varie sostanze psichedeliche, come gli psichedelici classici (psilocibina, ayahuasca e LSD) la ketamina e l'MDMA. Gli...

The feasibility and acceptability of Project POWER: a mindfulness-infused, cognitive-behavioral group intervention to address mental and sexual health needs of young pregnant women in Liberia

BMC Pregnancy and Childbirth March 20, 2023 Tamora A. Callands, Kandyce Hylick, Alethea Desrosiers et al. 7 citations

BACKGROUND: Following 14 years of civil war in Liberia, war exposure, gender-based violence, and extreme poverty have been identified as key challenges affecting the mental and sexual health of young pregnant women and the health of their unborn children. Despite ongoing efforts to rebuild the country's healthcare infrastructure, empirical and culturally tailored interventions to address the...

Review on "Sleep paralysis and trauma, psychiatric symptoms and disorders in an adult African American population attending primary medical care." by Johnson EO, Roth T, Breslau N.

March 20, 2023 Hafiza Khadija Shahid, Ruman Zahra, Afaq Ahmed

Article Reviewed: Title: "Sleep paralysis and trauma, psychiatric symptoms and disorders in an adult African American population attending primary medical care." Authors: Johnson EO, Roth T, Breslau N. Journal: Sleep, 2006 Jun;29(6):671-8. This research paper investigates the prevalence of sleep paralysis and its relationship to trauma, psychiatric symptoms, and disorders in an adult African...

DOI: 10.22541/au.167935469.99452214/v1 (opens in new tab) Sleep paralysis Generalizability theory Population Clinical psychology +3

The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice

Molecules March 14, 2023 Timur Zanikov, Marta Gerasymchuk, Gregory Ian Robinson et al. 48 citations

Inflammation is an organism’s biological defense mechanism. Acute and chronic inflammation of the body triggers the production of pro- and anti-inflammatory pathways that can affect the content of cytokines in the brain and thus cause brain inflammation. Disorders such as depression and posttraumatic stress disorder (PTSD) are often associated with elevated inflammation. Recently, positive and...

DOI: 10.3390/molecules28062624 (opens in new tab) Psilocybin Eugenol Inflammation Pharmacology +3

Should Psychedelic Drugs Be Offered as a Treatment for Mental Illness?

Journal of Humanities Arts and Social Science March 13, 2023 Ruoqi Zhang

Psychedelics are becoming increasingly popular as an entry point into difficult- to-treat psychiatric illnesses and a supplement to existing treatments. However, many people view these substances with caution due to increased incidents where they've been used illegally in unsupervised settings. This paper argues that adding psychedelics to the treatment of mental illness can be beneficial for...

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020

Journal of Psychopharmacology March 6, 2023 Emma I Kopra, Jason Ferris, Adam Winstock et al. 62 citations

Background: Growing numbers of people are using psychedelics for personal psychotherapy outside clinical settings, but research on such use is scarce. Aims: This study investigated the patterns of use, self-reported outcomes and outcome predictors of psychedelic ‘self-treatment’ of mental health conditions or specific worries/concerns in life. Methods: We use data from the Global Drug Survey...

Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training?

Cambridge Quarterly of Healthcare Ethics March 2, 2023 Nathan Emmerich, Bryce Humphries 27 citations

Recent research offers good reason to think that various psychedelic drugs-including psilocybin, ayahuasca, ketamine, MDMA, and LSD-may have significant therapeutic potential in the treatment of various mental health conditions, including post-traumatic stress disorder, depression, existential distress, and addiction. Although the use of psychoactive drugs, such as Diazepam or Ritalin, is well...

Manual development and efficacy of Mindful Living Group activities to promote trauma healing during the COVID-19 pandemic in China

Institutional Repository of Institute of Psychology, Chinese Academy of Sciences March 1, 2023 Ya-Nan Niu, Di Long

Introduction: Disasters can be traumatic with a profound and lasting impact on individuals. During the COVID-19 pandemic, our team developed the Mindful Living Group (MLG) activities manual based on Eastern body-mind wisdom and Western trauma healing theory to provide psychological assistance for trauma healing. Methods: In this study, we introduce a framework developed for the 10-session MLG...

A Pilot Study Comparing a Community of Practice Group Therapy Program with and without Concurrent Ketamine-assisted Therapy

European Psychiatry March 1, 2023 V. W. L. Tsang, R. Moyer, P. Kryskow et al. 2 citations

IntroductionHealthcare practitioners (HCPs) are facing a mental health crisis. Group therapies have long been used to treat symptoms associated with PTSD, anxiety and/or depression, however no studies have investigated the role of implementing group therapy with and without ketamine-assisted therapies (KaT).ObjectivesThe current study investigated the effects of the Roots to Thrive (RTT) group...